Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Alpine Immune Sciences
AddedFeb 19, 2024
UpdatedJun 18, 2026
Alpine Immune Sciences

Alpine Immune Sciences

Acquired

Alpine Immune Sciences, Inc.: A Seattle-based immunotherapy leader innovating treatments for autoimmune and inflammatory diseases.

HQ
Seattle, WA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Alpine Immune Sciences, Inc., based in Seattle, is a clinical-stage biopharmaceutical company specializing in innovative, protein-based immunotherapies for autoimmune and inflammatory diseases. The company's core mission is to harness the power of the immune system to develop transformative treatments. Alpine has advanced multiple product candidates into clinical trials and formed collaborations with leading partners, focusing on both autoimmune conditions and cancer.

Notable figures affiliated with Alpine include its experienced management team and scientific advisors, who have significantly contributed to its research and development capabilities. The company has achieved key milestones, including advancing its product candidates into clinical trials and forming strategic partnerships. The acquisition by Vertex Pharmaceuticals underscores Alpine's impact and potential in the biopharmaceutical industry, highlighting its contributions to advancing immunotherapy treatments.

Alpine Immune Sciences - Similar Companies

Inimmune logo

Inimmune

inimmune.com

Immunome logo

Immunome

ImmuneID logo

ImmuneID

Equillium logo

Equillium

equilliumbio.com

INmune Bio logo

INmune Bio

inmunebio.com

Asylia Therapeutics logo

Asylia Therapeutics

asyliatx.com

AIM Immunotech logo

AIM Immunotech

aimimmuno.com

Abacus Bioscience logo

Abacus Bioscience

ImmuneBridge logo

ImmuneBridge

immunebridge.com

IM Therapeutics logo

IM Therapeutics

imtherapeutics.com

HI-Bio logo

HI-Bio

hibio.com

Cleveland BioLabs logo

Cleveland BioLabs

ImmuneTarget logo

ImmuneTarget

Inmagene Biopharmaceuticals logo

Inmagene Biopharmaceuticals

inmagenebio.com

Apellis Pharmaceuticals logo

Apellis Pharmaceuticals

apellis.com

Alpine Immune Sciences - Quick Facts

Who are Alpine Immune Sciences' competitors?

Companies similar to Alpine Immune Sciences include Inimmune, Immunome, ImmuneID and Equillium.

When was Alpine Immune Sciences founded?

Alpine Immune Sciences was founded in 2015.

Where is Alpine Immune Sciences' headquarters located?

Alpine Immune Sciences' headquarters is located in Seattle, WA, US.

When was Alpine Immune Sciences' last funding round?

Alpine Immune Sciences' most recent funding round was for $150M (USD) in November 2023.

How much has Alpine Immune Sciences raised to-date?

As of Nov 6, 2023, Alpine Immune Sciences has raised a total of $475.3M (USD).

Alpine Immune Sciences - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Immunotherapies
  • Treatments
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 4000Railroad Transportation
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified